Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lokelma to Control Interdialytic Hyperkalemia in Hemodialysis Patients
NCT05535920Phase 4Completed
- Sponsor
- NephroNet
- Start
- Apr 2022
- Primary completion
- Apr 2024
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of sodium zirconium cyclosilicate in hyperkalemia, sponsored by NephroNet. Started Apr 2022; status: completed.
02
Drugs
sodium zirconium cyclosilicate
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on NCT05535920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05535920.